Voyager Therapeutics, Inc. - VYGR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 18, 2026 | SCHEDULE 13G/A | Armistice Capital, LLC | 7.19% | 4,000,000 | View |
| Feb 18, 2026 | SCHEDULE 13G/A | Steven Boyd | 7.19% | 4,000,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | EcoR1 Capital, LLC | 6.8% | 4,002,847 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Oleg Nodelman | 6.8% | 4,002,847 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | EcoR1 Capital Fund Qualified, L.P. | 6.4% | 3,756,988 | View |
| Jan 26, 2026 | SCHEDULE 13G | Integrated Core Strategies (US) LLC | 6.0% | 3,338,862 | View |
| Jan 26, 2026 | SCHEDULE 13G | Millennium Management LLC | 6.1% | 3,407,969 | View |
| Jan 26, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 6.1% | 3,407,969 | View |
| Jan 26, 2026 | SCHEDULE 13G | Israel A. Englander | 6.1% | 3,407,969 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Armistice Capital, LLC | 7.57% | 4,200,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven Boyd | 7.57% | 4,200,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | EcoR1 Capital, LLC | 6.8% | 4,003,636 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Oleg Nodelman | 6.8% | 4,003,636 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | EcoR1 Capital Fund Qualified, L.P. | 6.4% | 3,738,856 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.